Open AccessComparative clinical and economic assessment of polatuzumab vedotin therapy in combination with bendamustine and rituximab for adult transplantation-ineligible patients with relapsed/refractory diffuse large B-cell lymphoma
Author(s) -
I. N. Dyakov,
К. К. Бушкова
Publication year - 2022
Publication title -
onkogematologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.118
H-Index - 3
eISSN - 2413-4023
pISSN - 1818-8346
DOI - 10.17650/1818-8346-2022-17-3-160-170
Subject(s) - bendamustine , brentuximab vedotin , rituximab , medicine , oncology , refractory (planetary science) , transplantation , autologous stem cell transplantation , clinical trial , diffuse large b cell lymphoma , lymphoma , hodgkin lymphoma , physics , astrobiology